Evidence map›Paper›PMID 41104619›Full record

ArticleeLife2025

scRNA+TCR-seq reveals the proportion and characteristics of dual TCR Treg cells in mouse lymphoid and non-lymphoid tissues.

Yuanyuan Xu, Qi Peng, Xiaoping Lu, Long Ma, Jun Li, Xinsheng Yao

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuanyuan XuDepartment of Immunology, Zunyi Medical University; Guizhou Provincial Research Center for Applied Immunomolecular Engineering; Guizhou Provincial Innovation Base for Graduate Education in Immunology; Guizhou Provincial Key Discipline of Immunology, Zunyi, China.ORCID https://orcid.org/0009-0008-5750-445X
Qi PengDepartment of Immunology, Zunyi Medical University; Guizhou Provincial Research Center for Applied Immunomolecular Engineering; Guizhou Provincial Innovation Base for Graduate Education in Immunology; Guizhou Provincial Key Discipline of Immunology, Zunyi, China.
Xiaoping LuDepartment of Immunology, Zunyi Medical University; Guizhou Provincial Research Center for Applied Immunomolecular Engineering; Guizhou Provincial Innovation Base for Graduate Education in Immunology; Guizhou Provincial Key Discipline of Immunology, Zunyi, China.
Long MaDepartment of Immunology, Zunyi Medical University; Guizhou Provincial Research Center for Applied Immunomolecular Engineering; Guizhou Provincial Innovation Base for Graduate Education in Immunology; Guizhou Provincial Key Discipline of Immunology, Zunyi, China.
Jun LiDepartment of Immunology, Zunyi Medical University; Guizhou Provincial Research Center for Applied Immunomolecular Engineering; Guizhou Provincial Innovation Base for Graduate Education in Immunology; Guizhou Provincial Key Discipline of Immunology, Zunyi, China.
Xinsheng YaoDepartment of Immunology, Zunyi Medical University; Guizhou Provincial Research Center for Applied Immunomolecular Engineering; Guizhou Provincial Innovation Base for Graduate Education in Immunology; Guizhou Provincial Key Discipline of Immunology, Zunyi, China.ORCID https://orcid.org/0000-0001-6960-4003

Funding

Guizhou Provincial Science and Technology Department No. (2018)5637National Natural Science Foundation of China 82160279National Natural Science Foundation of China 82471630
6 · The paper itself

Abstract

The rearrangement of TCR germline V(D)J genes during T cell development, including allelic exclusion and tolerance selection, ensures the clonal selection theory, which states that 'a lymphocyte expresses only one type of antigen receptor'. This forms the basis for T cell-specific responses. However, the existence of 'dual TCR T cells' has consistently been supported by specific experimental evidence. Detailed reports on the origin, proportion, tissue distribution, and CDR3 characteristics of 'dual TCR Treg cells' are currently lacking. In this study, we utilized scRNA+TCR-seq technology to achieve in-depth analysis of single and dual TCR T pairings, along with their mRNA expressions, from over 5000 T cells in each sample. Through comparative studies with shared databases, we provided a detailed analysis of the proportions and characteristics of dual TCR Tregs in mouse lymphoid and non-lymphoid tissues (such as inguinal lymph node, mesenteric lymph node, blood, and skin). Our findings revealed a high proportion of dual TCR Tregs across various mouse tissues, with their TCR pairing patterns, V(D)J usage, and mRNA expression showing both homogeneity and certain differences compared to single TCR Tregs, as well as heterogeneity across different tissue sites. This research provides new insights and technical approaches for studying the origins, characteristics, effects, and mechanisms of Treg cells in different tissue locations.

Indexed as

Lymphoid TissueReceptors, Antigen, T-CellT-Lymphocytes, RegulatoryAnimalsMiceMice, Inbred C57BLReceptors, Antigen, T-Cellimmunologyinflammationlymphoid tissuesmouseMousenon-lymphoid tissues

Identifiers

PMID41104619
PMCPMC12534043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.